fda bpc-157 category 2 compounding list Exciting news for peptides coming out of today's committee hearing! The Pharmacy Advisory Committee voted 8-6 to recommend adding BPC- 157 to the 503A Bulks for use in compounding for Regulatory Alert: FDA's April 2026

Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step 3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval FDA's Overreach on Compounded Peptides FDA Peptide Update: Category 2 Removals Explained

SKU: 70561565789 · From hgidocs.co